Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: a case report.

Heo JW, Kim SW, Cho EH.

Diabetes Res Clin Pract. 2013 Apr;100(1):e1-2. doi: 10.1016/j.diabres.2013.01.016. Epub 2013 Feb 21.

PMID:
23434183
[PubMed - indexed for MEDLINE]
2.

Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.

Al-Mahdi M, Al Mutair A, Al Balwi M, Hussain K.

Ann Saudi Med. 2010 Mar-Apr;30(2):162-4. doi: 10.4103/0256-4947.60526. Erratum in: Ann Saudi Med. 2010 May-Jun;30(3):242.

PMID:
20220270
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required.

Babiker T, Shepherd MH, Hattersley AT.

Diabetes Res Clin Pract. 2013 Jun;100(3):e63. doi: 10.1016/j.diabres.2013.03.029. Epub 2013 Apr 19. No abstract available.

PMID:
23608551
[PubMed - indexed for MEDLINE]
4.

Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.

Chan YM, Laffel LM.

Pediatr Diabetes. 2007 Aug;8(4):235-8.

PMID:
17659066
[PubMed - indexed for MEDLINE]
5.

Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.

Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Ciljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I.

J Clin Endocrinol Metab. 2007 Apr;92(4):1276-82. Epub 2007 Jan 9.

PMID:
17213273
[PubMed - indexed for MEDLINE]
6.

Transfer from insulin to sulfonylurea treatment in a chinese patient with permanent neonatal diabetes mellitus due to a KCNJ11 R201H mutation.

Xiao X, Wang T, Li W, Song H, Gong C, Diao C, Yu M, Yuan T, Zhang Y, Sun X, Zhang Q, Lu K, Wang H, Schmitz O, Hansen T.

Horm Metab Res. 2009 Jul;41(7):580-2. doi: 10.1055/s-0029-1192020. Epub 2009 Feb 26. No abstract available.

PMID:
19247925
[PubMed - indexed for MEDLINE]
7.

Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases.

Gaal Z, Klupa T, Kantor I, Mlynarski W, Albert L, Tolloczko J, Balogh I, Czajkowski K, Malecki MT.

Diabetes Care. 2012 Jun;35(6):e40. doi: 10.2337/dc12-0163. No abstract available.

PMID:
22619292
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet.

Delvecchio M, Zecchino C, Faienza MF, Acquafredda A, Barbetti F, Cavallo L.

Diabetes Res Clin Pract. 2009 Jun;84(3):332-4. doi: 10.1016/j.diabres.2009.02.024. Epub 2009 Apr 3.

PMID:
19345438
[PubMed - indexed for MEDLINE]
9.

Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.

Ješić MM, Ješić MD, Maglajlić S, Sajić S, Necić S.

Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5.

PMID:
21056492
[PubMed - indexed for MEDLINE]
10.

Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy.

Wagner VM, Kremke B, Hiort O, Flanagan SE, Pearson ER.

Eur J Pediatr. 2009 Mar;168(3):359-61. doi: 10.1007/s00431-008-0757-3. Epub 2008 Jun 12.

PMID:
18548275
[PubMed - indexed for MEDLINE]
11.

Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.

Bremer AA, Ranadive S, Lustig RH.

Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24.

PMID:
18221420
[PubMed - indexed for MEDLINE]
12.

Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2.

Kim MS, Kim SY, Kim GH, Yoo HW, Lee DW, Lee DY.

J Korean Med Sci. 2007 Aug;22(4):616-20.

PMID:
17728498
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy--a three-year follow-up.

Begum-Hasan J, Polychronakos C, Brill H.

J Pediatr Endocrinol Metab. 2008 Sep;21(9):895-903.

PMID:
18924582
[PubMed - indexed for MEDLINE]
14.

Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.

Philla KQ, Bauer AJ, Vogt KS, Greeley SA.

Diabetes Care. 2013 Dec;36(12):e201. doi: 10.2337/dc13-1690. Review. No abstract available. Erratum in: Diabetes Care. 2014 Feb;37(2):588.

PMID:
24265373
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation.

Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, Malecki MT.

Diabetologia. 2005 May;48(5):1029-31. Epub 2005 Apr 19. No abstract available.

PMID:
15838686
[PubMed - indexed for MEDLINE]
16.

Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus.

Ting WH, Huang CY, Lo FS, Lee HC, Lin CL, Guo WL, Lee YJ.

J Pediatr Endocrinol Metab. 2009 Jul;22(7):661-7.

PMID:
19774848
[PubMed - indexed for MEDLINE]
17.

Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas.

Dupont J, Pereira C, Medeira A, Duarte R, Ellard S, Sampaio L.

J Pediatr Endocrinol Metab. 2012;25(3-4):367-70.

PMID:
22768671
[PubMed - indexed for MEDLINE]
18.

Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.

Abbasi F, Saba S, Ebrahim-Habibi A, Sayahpour FA, Amiri P, Larijani B, Amoli MM.

Mol Diagn Ther. 2012 Apr 1;16(2):109-14. doi: 10.2165/11599600-000000000-00000.

PMID:
22471336
[PubMed - indexed for MEDLINE]
19.

Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.

Wambach JA, Marshall BA, Koster JC, White NH, Nichols CG.

Pediatr Diabetes. 2010 Jun;11(4):286-8. doi: 10.1111/j.1399-5448.2009.00557.x. Epub 2009 Jul 29.

PMID:
19656320
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.

Tonini G, Bizzarri C, Bonfanti R, Vanelli M, Cerutti F, Faleschini E, Meschi F, Prisco F, Ciacco E, Cappa M, Torelli C, Cauvin V, Tumini S, Iafusco D, Barbetti F; Early-Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology.

Diabetologia. 2006 Sep;49(9):2210-3. Epub 2006 Jul 1. No abstract available.

PMID:
16816952
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk